临床试验/TCTR20220112002

TCTR20220112002招募中4 期

Safety and immunogenicity of intradermal and intramuscular booster COVID-19 vaccination following the 2-dose primary series of ChAdOx1(AstraZeneca) in Thai older people)

Faculty of Medicine Siriraj Hospital, Mahidol University0 个研究点目标入组 210 人开始时间: 2022年1月12日最近更新: 2024年8月19日

适应症

试验速览

阶段: 4 期
状态: 招募中
发起方: Faculty of Medicine Siriraj Hospital, Mahidol University
入组人数: 210

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 65 Years 至 N/A (No limit)（—）
性别: All

入选标准

•1. Aged 65 years old or more. 2. Having a 2-dose primary series of ChAdOx1 (AstraZeneca) vaccine for 12-24 weeks. 3. Stable and well-controlled chronic diseases. 4. Ability to understand and communicate in Thai language. 5. Ability to attend the appointment. 6.Ability to give informed consent

排除标准

•1. Having a history of anaphylaxis to drug or other vaccines. 2. Having a previous history of Covid-19 infection or high-risk of Covid-19 infection. 3. Having any type of vaccination 2 week before the recruitment. 4. Having any type of immunodeficiency. 5. Taking any type of immunosuppressive agent or cytotoxic drug. 6. No acute illness or acute inflammation. 7. Having blood transfusion or other blood products, immunoglobulin, antiviral agent, or antibody within previous 90 days.

研究者

发起方

Faculty of Medicine Siriraj Hospital, Mahidol University

相似试验

Immunogenicity and safety of intradermal injection of reduced dose Inactivated Poliovirus vaccine (IPV) with a jet injector in healthy adultsinfantile paralysispolio10047438

NL-OMON32437ederlands Vaccin Instituut120

进行中（未招募）

Immunogenicity and safety of intradermal injection of reduced dose Inactivated Poliovirus vaccine (IPV) with a jet injector in healthy adults - Intradermal injection of reduced dose IPV in adults

EUCTR2009-015175-27-NLetherlands Vaccine Institute

Onderzoek naar de bijwerkingen en immuunrespons na een boostervaccinatie tegen polio, toegediend met een naaldloze Jet Injector.poliomyelitis, polio, vaccination, vaccinatie, intradermal, intradermaal, jet injector, needle-free, naaldloos

NL-OMON26044etherlands Vaccine Institute RIVM, formerly Nederland Vaccine, Institute (NVI)120

Assessment of the effect of exosomes in the treatment of melasma

IRCT20221130056672N6Tehran University of Medical Sciences30

Comparative study of Intradermal versus Intralesional Purified Protein Derivative (PPD) for treatment of common warts in childre

CTRI/2019/07/020070Himachal Pradesh University